Close
Kapoose Creek Bio, a Vancouver-based biotechnology company, has identified and advanced two lead compounds with promising potential in neurology. Leveraging AI for drug discovery from nature, the company's announcement signifies a significant step forward in the field of neurology.
The advancement of these potent compounds showcases the innovative approach of Kapoose Creek Bio in utilizing AI technology for drug discovery. With the identification of these compounds, the company is poised to make a significant impact in the field of neurology, offering new possibilities for treatment and research.
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.
Log in
Sign Up
AI Tools - Popular
AI Tools - Categories
GPTs - Categories
AI for Jobs
